
Evaluating the addition of a platinum agent to a taxane in metastatic breast cancer and the benefits for TNBC. A Romanian centre experience
Author(s) -
Silvia Moşoiu,
Laurenţia Galeş,
Denisa Ciochir
Publication year - 2021
Publication title -
oncolog-hematolog.ro
Language(s) - English
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.5.1.2021.4569
Subject(s) - carboplatin , taxane , triple negative breast cancer , medicine , oncology , breast cancer , paclitaxel , metastatic breast cancer , docetaxel , triple negative , cancer , chemotherapy , cisplatin